Acute leukemias discussion: what does genomics and epigenomics tell us about patient management?
Ari Melnick et al.
The future of AML and MDS diagnosis and treatment
Stéphane de Botton
Why should elderly AML patients take part in clinical trials?
HARMONY: a collaboration between 51 partners
The spliceosome mutations that can cause hematological malignancies